Park Ha Biological Technology is trading 7.2% down at $0.45 today with no clear catalyst, extending recent volatility after sharp swings over the past week.
- The drop appears driven by low-priced, low-liquidity trading rather than fresh fundamental news, as no new filings or headlines surfaced overnight to explain the move.
- Recent company updates include a $2 million registered direct offering and an AI-focused strategic partnership, but these do not account for the latest downward pressure.